பார்மா பிரைவேட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பார்மா பிரைவேட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பார்மா பிரைவேட் Today - Breaking & Trending Today

Outlook on the Dry Eye Disease (DED) Global Market to 2026


4. Global Dry Eye Disease Market: Sizing and Forecast
5. Global Dry Eye Disease Market Segmentation By Disease, By Treatment, By End User, By Distribution Channel
5.1 Competitive Scenario of Global Dry Eye Disease Market: By Disease
5.1.1 Aqueous n Market Size and Forecast (2016-2026)
5.1.2 Evaporative n Market Size and Forecast (2016-2026)
5.1.3 Others n Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Dry Eye Disease Market: By Treatment
5.2.1 Eye Drops n Market Size and Forecast (2016-2026)
5.2.2 Anti-Inflammatory Drugs n Market Size and Forecast (2016-2026)
5.2.3 Others n Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Dry Eye Disease Market: By End User
5.3.1 Home Healthcare n Market Size and Forecast (2016-2026) ....

United States , Hong Kong , United Kingdom , South Korea , Novaliq Gmb , Asia Pacific , Company Profiles Business Description , Research Methodology , Sentiss Pharma Pvt Ltd , Santen Pharmaceuticals Co , Bausch Health , Dry Eye Disease , End User , Distribution Channel , Market Insights , Evaporative Dry Eye Disease , North America , Dry Eye Disease Market By , Eye Drops , Anti Inflammatory Drugs , Home Healthcare , Hospital Pharmacies , Global Dry Eye Disease Market , Major Mergers , Technological Innovations , Santen Pharmaceuticals ,

Worldwide Dry Eye Disease (DED) Industry to 2026 - by Disease, Treatment, End-user, Distribution Channel and Region


4. Global Dry Eye Disease Market: Sizing and Forecast
5. Global Dry Eye Disease Market Segmentation By Disease, By Treatment, By End User, By Distribution Channel
5.1 Competitive Scenario of Global Dry Eye Disease Market: By Disease
5.1.1 Aqueous n Market Size and Forecast (2016-2026)
5.1.2 Evaporative n Market Size and Forecast (2016-2026)
5.1.3 Others n Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Dry Eye Disease Market: By Treatment
5.2.1 Eye Drops n Market Size and Forecast (2016-2026)
5.2.2 Anti-Inflammatory Drugs n Market Size and Forecast (2016-2026)
5.2.3 Others n Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Dry Eye Disease Market: By End User
5.3.1 Home Healthcare n Market Size and Forecast (2016-2026) ....

United States , Hong Kong , United Kingdom , South Korea , Novaliq Gmb , Asia Pacific , Laura Wood , Office Hours Call , Research Methodology , Sentiss Pharma Pvt Ltd , Santen Pharmaceuticals Co , E St Office Hours Call , Company Profiles Business Description , Bausch Health , Dry Eye Disease , End User , Distribution Channel , Market Insights , Evaporative Dry Eye Disease , North America , Dry Eye Disease Market By , Eye Drops , Anti Inflammatory Drugs , Home Healthcare , Hospital Pharmacies , Global Dry Eye Disease Market ,

10,000 doses of CanSino vaccine gathering dust in Karachi


10,000 doses of CanSino vaccine gathering dust in Karachi
Top Story
April 17, 2021
KARACHI: At a time when Pakistan is desperately looking for COVID-19 vaccines to inoculate millions of people, 10,000 doses of single-dose Chinese vaccine Convidecia, imported by a private firm in Pakistan, are lying useless at a warehouse in Karachi, at least for the last 10 days as Drug Regulatory Authority of Pakistan (DRAP) is awaiting ‘some documents’ to release the consignment, The News has learnt.
“10,000 doses of Convidecia vaccine, developed by the CanSino Biologics Inc, had arrived in Karachi at least 10 days ago. This shipment was imported by a private firm AJM Limited and it was to be supplied to three hospitals in the country but it has not yet been released by the DRAP due to red-tapism,” an official of the National Health Services, Regulations and Coordination (NHS,R&C) told The News on Friday. ....

Shifa International Hospital , Cansino Convidecia , Pharma Pvt , China Cansino Biologics Inc , Adult Vaccination Centers , Cansino Biologics Inc , Drug Regulatory Authority Of Pakistan , Aga Khan University Hospital , National Health Services , Drug Regulatory Authority , Pvt Limited , Karachi Airport , Sino Biologics Inc , Shaukat Khanum Hospital , ஷிஃபா சர்வதேச மருத்துவமனை , பார்மா பிரைவேட் , சீனா கேன்சினோ உயிரியல் இன்க் , கேன்சினோ உயிரியல் இன்க் , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , தேசிய ஆரோக்கியம் சேவைகள் , மருந்து ஒழுங்குமுறை அதிகாரம் , பிரைவேட் வரையறுக்கப்பட்டவை , கராச்சி விமான , சினோ உயிரியல் இன்க் , ஷௌுகத் காணும் மருத்துவமனை ,

Pakistan allows Chinese Convidicea Vaccine for COVID-19


Top Story
February 13, 2021
KARACHI: The registration board of Drug Regulatory Authority of Pakistan (DRAP) on Friday allowed emergency use of single-dose of Chinese Convidicea Vaccine (Ad5-nCoV) for COVID-19, developed by Chinese biopharmaceutical company CanSino Biologicals Inc., officials told ‘The News’.
Special Assistant to the Prime Minister (SAPM) on Health, Dr Faisal Sultan, also confirmed that the drug regulator has approved the emergency use of Ad5-nCoV in Pakistan on the recommendations of an experts committee, which had been constituted to assess the safety and efficacy of the vaccine, responsible to decide, whether the vaccine should be administered to people or not. The officials said the registration board of the DRAP has shown a positive nod to the manufacturer of coronavirus vaccine, after the committee comprising six infectious diseases experts, including pathologists and others, assessed the results and data submitted by the company and recommen ....

United Kingdom , Faisal Sultan , Pharma Pvt , Drug Regulatory Authority Of Pakistan , Cansino Biologicals Inc , Drug Regulatory Authority , Chinese Convidicea Vaccine , Prime Minister , Convidicea Vaccine , Co Vid , ஒன்றுபட்டது கிஂக்டம் , ஃபேஸல் சுல்தான் , பார்மா பிரைவேட் , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , கேன்சினோ உயிரியல் இன்க் , மருந்து ஒழுங்குமுறை அதிகாரம் , ப்ரைம் அமைச்சர் , இணை வித் ,